Chen-Yuan Lin

1.7k total citations · 1 hit paper
18 papers, 1.0k citations indexed

About

Chen-Yuan Lin is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Chen-Yuan Lin has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Chen-Yuan Lin's work include Esophageal Cancer Research and Treatment (4 papers), Colorectal and Anal Carcinomas (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Chen-Yuan Lin is often cited by papers focused on Esophageal Cancer Research and Treatment (4 papers), Colorectal and Anal Carcinomas (3 papers) and Gastric Cancer Management and Outcomes (3 papers). Chen-Yuan Lin collaborates with scholars based in Taiwan, United States and Japan. Chen-Yuan Lin's co-authors include Chih‐Hung Hsu, Yutaro Kubota, Yuko Kitagawa, Yasuo Hamamoto, Shigenori Kadowaki, Chueh‐Chuan Yen, Masanobu Takahashi, Byoung Chul Cho, Morihito Okada and Myung‐Ju Ahn and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Chen-Yuan Lin

18 papers receiving 1.0k citations

Hit Papers

Nivolumab versus chemotherapy in patients with advanced o... 2019 2026 2021 2023 2019 250 500 750

Peers

Chen-Yuan Lin
Chen-Yuan Lin
Citations per year, relative to Chen-Yuan Lin Chen-Yuan Lin (= 1×) peers Birgit Gruenberger

Countries citing papers authored by Chen-Yuan Lin

Since Specialization
Citations

This map shows the geographic impact of Chen-Yuan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen-Yuan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen-Yuan Lin more than expected).

Fields of papers citing papers by Chen-Yuan Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chen-Yuan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen-Yuan Lin. The network helps show where Chen-Yuan Lin may publish in the future.

Co-authorship network of co-authors of Chen-Yuan Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chen-Yuan Lin. A scholar is included among the top collaborators of Chen-Yuan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chen-Yuan Lin. Chen-Yuan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cheng, Wei‐Chung, Wei-Chao Chang, Guan-Chin Tseng, et al.. (2021). ADAM9 functions as a transcriptional regulator to drive angiogenesis in esophageal squamous cell carcinoma. International Journal of Biological Sciences. 17(14). 3898–3910. 13 indexed citations
2.
Wang, Wei‐Jan, et al.. (2021). Imatinib (STI571) Inhibits the Expression of Angiotensin-Converting Enzyme 2 and Cell Entry of the SARS-CoV-2-Derived Pseudotyped Viral Particles. International Journal of Molecular Sciences. 22(13). 6938–6938. 8 indexed citations
3.
Lin, Chen-Yuan, Hsin-Yuan Fang, Ching‐Chan Lin, et al.. (2020). Clinical Outcomes and Prognostic Factors of Patients With Esophageal Squamous Cell Carcinoma With Oligo-recurrence Treated With Radical Re-irradiation. Anticancer Research. 40(4). 2387–2392. 2 indexed citations
5.
Kato, Ken, Byoung Chul Cho, Masanobu Takahashi, et al.. (2019). Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTION-3): a multicentre, randomised, open-label, phase 3 trial. The Lancet Oncology. 20(11). 1506–1517. 751 indexed citations breakdown →
6.
Lo, Wen-Jyi, Li-Yuan Bai, Chen-Yuan Lin, et al.. (2018). Total body irradiation tremendously impair the proliferation, differentiation and chromosomal integrity of bone marrow-derived mesenchymal stromal stem cells. Annals of Hematology. 97(4). 697–707. 13 indexed citations
7.
Huang, Shang‐Yi, Ming Yao, Chen-Yuan Lin, et al.. (2018). Autologous stem cell transplantation in multiple myeloma: Post-transplant outcomes of Taiwan Blood and Marrow Transplantation Registry. Journal of the Formosan Medical Association. 118(1). 471–480. 3 indexed citations
8.
Lin, Chen-Yuan, Li‐Ju Wang, Ching‐Chan Lin, et al.. (2017). ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT. Scientific Reports. 7(1). 15108–15108. 38 indexed citations
9.
Hsieh, Te‐Chun, et al.. (2016). A Mimic of Intra-abdominal Malignancy. Clinical Nuclear Medicine. 41(6). 466–468. 3 indexed citations
10.
Chiu, Kuo-Liang, et al.. (2015). ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis. Scientific Reports. 5(1). 16426–16426. 29 indexed citations
11.
Lin, Chen-Yuan, Hung‐Jen Chen, Liang‐Chuan Lai, et al.. (2014). ADAM9 Promotes Lung Cancer Metastases to Brain by a Plasminogen Activator-Based Pathway. Cancer Research. 74(18). 5229–5243. 69 indexed citations
12.
Chen, Shang-Wen, Te‐Chun Hsieh, Hueisch‐Jy Ding, et al.. (2013). Pretreatment metabolic tumor volumes to predict the short-term outcome of unresectable locally advanced squamous cell carcinoma of the esophagus treated with definitive chemoradiotherapy. Nuclear Medicine Communications. 35(3). 291–297. 24 indexed citations
13.
Lin, Ching‐Chan, Tzu-Ting Chen, Chen-Yuan Lin, et al.. (2013). Prognostic Analysis of Adjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma. Future Oncology. 9(10). 1469–1476. 6 indexed citations
14.
Chang, Hui-Wen, et al.. (2012). The clinical features and prognosis of phyllodes tumors: a single institution experience in Taiwan. International Journal of Clinical Oncology. 18(4). 614–620. 30 indexed citations
15.
Yeh, Su-Peng, Wen-Jyi Lo, Yu-Min Liao, et al.. (2011). Anti-leukemic therapies induce cytogenetic changes of human bone marrow-derived mesenchymal stem cells. Annals of Hematology. 91(2). 163–172. 10 indexed citations
16.
Liao, Yu-Min, et al.. (2008). Oxaliplatin-induced long QT syndrome in a patient with appendiceal adenocarcinoma. Acta Oncologica. 48(1). 156–157. 5 indexed citations
17.
Bai, Li-Yuan, et al.. (2007). Recurrent Lymphoma Presenting As Brachial Plexus Neuropathy. Journal of Clinical Oncology. 25(6). 726–728. 4 indexed citations
18.
Lin, Chen-Yuan, et al.. (2006). Perianal tuberculosis during neutropenia: a rare case report and review of literature. Annals of Hematology. 85(8). 547–548. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026